Authors:
Zhu, ZW
Friess, H
Wang, L
Bogardus, T
Korc, R
Kleeff, J
Buchler, MW
Citation: Zw. Zhu et al., Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells, CLIN CANC R, 7(1), 2001, pp. 105-112
Authors:
Kleeff, J
Shi, X
Bode, HP
Hoover, K
Shrikhande, S
Bryant, PJ
Korc, M
Buchler, MW
Friess, H
Citation: J. Kleeff et al., Altered expression and localization of the tight junction protein ZO-1 in primary and metastatic pancreatic cancer, PANCREAS, 23(3), 2001, pp. 259-265
Authors:
Ozawa, F
Friess, H
Kleeff, J
Xu, ZW
Zimmermann, A
Sheikh, MS
Buchler, MW
Citation: F. Ozawa et al., Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer, CANCER LETT, 163(1), 2001, pp. 71-81
Authors:
Huang, Y
Friess, H
Kleeff, J
Esposito, I
Zhu, ZW
Liu, SL
Mok, SC
Zimmermann, A
Buchler, MW
Citation: Y. Huang et al., DOC-2/hDab2 expression is up-regulated in primary pancreatic cancer but reduced in metastasis, LAB INV, 81(6), 2001, pp. 863-873
Authors:
Xu, ZW
Friess, H
Solioz, M
Aebi, S
Korc, M
Kleeff, J
Buchler, MW
Citation: Zw. Xu et al., Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine, INT J CANC, 94(2), 2001, pp. 268-274
Authors:
Zhu, ZW
Friess, H
Wang, L
Abou-Shady, M
Zimmermann, A
Lander, AD
Korc, M
Kleeff, J
Buchler, MW
Citation: Zw. Zhu et al., Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders, GUT, 48(4), 2001, pp. 558-564
Authors:
Liao, Q
Ozawa, F
Friess, H
Zimmermann, A
Takayama, S
Reed, JC
Kleeff, J
Buchler, MW
Citation: Q. Liao et al., The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer andinduced by heat stress in pancreatic cancer cell lines, FEBS LETTER, 503(2-3), 2001, pp. 151-157
Authors:
Matsuda, K
Maruyama, H
Guo, F
Kleeff, J
Itakura, J
Matsumoto, Y
Lander, AD
Korc, M
Citation: K. Matsuda et al., Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells, CANCER RES, 61(14), 2001, pp. 5562-5569
Authors:
Friess, H
Ding, JY
Kleeff, J
Liao, Q
Berberat, PO
Hammer, J
Buchler, MW
Citation: H. Friess et al., Identification of disease-specific genes in chronic pancreatitis using DNAarray technology, ANN SURG, 234(6), 2001, pp. 769-778
Authors:
Lu, Z
Kleeff, J
Shrikhande, S
Zimmermann, A
Korc, M
Friess, H
Buchler, MW
Citation: Z. Lu et al., Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer, PANCREAS, 21(3), 2000, pp. 240-247
Authors:
Conejo, JR
Kleeff, J
Koliopanos, A
Matsuda, K
Zhu, ZW
Goecke, H
Bicheng, N
Zimmermann, A
Korc, M
Friess, H
Buchler, MW
Citation: Jr. Conejo et al., Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers, INT J CANC, 88(1), 2000, pp. 12-20
Authors:
Zhu, ZW
Kleeff, J
Friess, H
Wang, L
Zimmermann, A
Yarden, Y
Buchler, MW
Korc, M
Citation: Zw. Zhu et al., Epiregulin is up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth, BIOC BIOP R, 273(3), 2000, pp. 1019-1024
Authors:
Kleeff, J
Wildi, S
Kumbasar, A
Friess, H
Lander, AD
Korc, M
Citation: J. Kleeff et al., Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells, PANCREAS, 19(3), 1999, pp. 281-288
Citation: J. Kleeff et al., Ligand induced upregulation of the type II transforming growth factor (TGF-beta) receptor enhances TGF-beta responsiveness in COLO-357 cells, PANCREAS, 18(4), 1999, pp. 364-370